According to the latest data from the Hong Kong Stock Exchange, Schroders increased its holding in Hengrui Pharma (01276) by 948,800 shares on June 12.

The purchase price was approximately HK$54.54 per share, resulting in a total investment of around HK$51.75 million.

Following this transaction, Schroders' latest shareholding stands at approximately 13.20 million shares, representing a 5.11% stake in the company.